The Research and Development team at Indapta Therapeutics is dedicated to advancing innovative cell therapies for cancer treatment. This multidisciplinary group collaborates on preclinical and translational research, regulatory compliance, and clinical oversight to ensure the efficacy and safety of their allogeneic G-NK cell therapy. Through a combination of scientific expertise and strategic leadership, they drive the pipeline from discovery to clinical application.
View all